Skip to main content

Advertisement

Log in

Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Nosocomial fungal infection increases gradually and has become the leading pathogen at National Taiwan University Hospital since 1993. From January 1995 through May 2002, hepatosplenic fungal infection (HSF) was diagnosed in 37 (7.4%) of the 500 adult patients with acute leukemia who received chemotherapy at this hospital. There was no significant difference in the incidence of HSF between the patients with acute myeloid leukemia and those with acute lymphoblastic leukemia, or between the patients treated with high-dose chemotherapy and those with conventional or low-dose chemotherapy. Candida tropicalis was the leading pathogen, followed by Candida albicans. The computed tomography scan showed multiple hypodense lesions in the liver (89%), spleen (70%), and kidney (27%). Eighteen patients were initially treated with fluconazole and 19 with amphotericin B. Nineteen patients received the planned chemotherapy after the diagnosis of HSF. Among them, eight patients underwent hematopoietic stem cell transplantation and seven patients survived more than 100 days post-transplantation; none of these patients had relapse of prior HSF. Twenty-three patients (62%) died during a median follow up of 10 months, but only seven died due to HSF. In conclusion, a substantial percentage of patients with acute leukemia acquired HSF after chemotherapy and carried high mortality. However, HSF itself is not a contraindication for subsequent chemotherapy and hematopoietic stem cell transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. DeGregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA (1982) Fungal infection in patients with acute leukemia. Am J Med 73:543–548

    Article  CAS  PubMed  Google Scholar 

  2. Antilla VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P (1997) Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 24:375–380

    Article  Google Scholar 

  3. Bjerke JW, Meyers JD, Bowden RA (1994) Hepatosplenic candidiasis: a contraindication to marrow transplantation. Blood 84:2811–2814

    CAS  PubMed  Google Scholar 

  4. Sallah S (1999) Hepatosplenic candidiasis in patients with acute leukemia: increasingly encountered complication. Anticancer Res 19:757–760

    CAS  PubMed  Google Scholar 

  5. Rossetti F, Brawner DL, Bowden R, Meyer WG, Schoch HG, Fisher L, Myerson D, Hackman RC, Shulman HM, Sale GE, Meyers JD, McDonald GB (1995) Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors and clinical features. Clin Infect Dis 20:801–811

    Article  CAS  PubMed  Google Scholar 

  6. Sallah S, Semelka RC, Wehbie R, Sallah W, Nguyen NP, Vos P (1999) Hepatosplenic candidiasis in patients with acute leukemia. Br J Hematol 106:697–701

    Article  CAS  Google Scholar 

  7. Haron E, Feld R, Tuffinell P, Patterson B, Hasselback R, Maltow A (1987) Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med 83:17–26

    Article  CAS  PubMed  Google Scholar 

  8. Anttila VJ, Ruutu P, Bondestam S, Jansson SE, Nordling S, Farkkila M, Sivonen A, Castren M, Ruutu T (1994) Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis 18:979–981

    Article  CAS  PubMed  Google Scholar 

  9. Anttila VJ, Farkkila M, Jansson SE, Taavitsainen M, Kaukoranta-Tolvanen SS, Nordling S, Koukila-kahkola P, Ruutu T, Ruutu P (1997) Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasis. Eur J Clin Microbiol 16:637–643

    Article  CAS  Google Scholar 

  10. Pestalozzi BC, Krestin GP, Schanz U, Jacky E, Gmur J (1997) Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia. Blood 90:3858–3864

    CAS  PubMed  Google Scholar 

  11. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14

    Article  CAS  PubMed  Google Scholar 

  12. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678

    Article  CAS  PubMed  Google Scholar 

  13. Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT (1997) Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol 18:369–375

    Article  CAS  PubMed  Google Scholar 

  14. Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebeau B, Spence D, Krcmery V, De pauw B, Meunier F, et al. (1999) Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28:1071–1079

    Article  CAS  PubMed  Google Scholar 

  15. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors and predictors of mortality. Clin Infect Dis 15:414–421

    Article  CAS  PubMed  Google Scholar 

  16. Chen YC, Lin SF, Liu CJ, Jiang DD, Yang PC, Chang SC (2001) Risk factors for ICU mortality in critically ill patients. J Formos Med Assoc 100:656–661

    CAS  PubMed  Google Scholar 

  17. Chen YC, Chang SC, Tai HM, Hsueh PR, Luh KT (2001) Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 100:791–797

    CAS  PubMed  Google Scholar 

  18. Woolley I, Curtis D, Szer J, Fairley C, Vujovic O, Ugoni A, Spelman D (1997) High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia. Leuk Lymphoma 27:469–474

    Article  CAS  PubMed  Google Scholar 

  19. Semelka RC, Kelekis N, Sallah S, Worawattanakul S, Ascher SM (1997) Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol 169:1311–1316

    Article  CAS  PubMed  Google Scholar 

  20. Sallah S, Semelka RC, Kelekis N, Worawattanakul S, Sallah W (1998) Diagnosis and monitoring response to treatment of hepatosplenic candidiasis in patients with acute leukemia using magnetic resonance imaging. Acta Hematol 100:77–81

    Article  CAS  Google Scholar 

  21. Shirkhoda A (1987) CT findings in hepatosplenic and renal candidiasis. J Comput Assist Tomogr 11:795–798

    Article  CAS  PubMed  Google Scholar 

  22. Pastakia B, Shawker TH, Thaler M, O'Leary T, Pizzo PA (1998) Hepatosplenic candidiasis: wheels within wheels. Radiology 166:417–421

    Article  Google Scholar 

  23. Karthaus M, Ganser A (2000) Hepatosplenic candidiasis in patients with acute leukemia. Br J Haematol 109:672

    Article  CAS  PubMed  Google Scholar 

  24. Thaler M, Pastakia B, Shawker TH, O'leary T, Pizzo PA (1988) Hepatic candidiasis in cancer patients: the evolving pictures of the syndrome. Ann Intern Med 18:88–100

    Article  Google Scholar 

  25. Lewis JH, Patel HR, Zimmerman HJ (1982) The spectrum of hepatic candidiasis. Hepatology 2:479–487

    Article  CAS  PubMed  Google Scholar 

  26. Hung CC, Chen YC, Chang SC, Luh KT, Hsieh WC (1996) Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 95:19–28

    CAS  PubMed  Google Scholar 

  27. De Repentigny L, Phaneuf M, Mathieu LG (1992) Gastrointestinal colonization and systemic dissemination by C. albicans and C. tropicalis in intact and immunocompromised mice. Infect Immun 60:4907–4914

    Google Scholar 

  28. Wang JT, Yao M, Tang JL, Chang SC, Hung CC (2001) Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies. J Clin Oncol 19:4000–4001

    Article  CAS  PubMed  Google Scholar 

  29. Walsh TJ, Whitcomb PO, Revankar SG, Pizza PA (1995) Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer 76:2357–2362

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.-F. Tien.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, CY., Chen, YC., Tang, JL. et al. Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann Hematol 82, 93–97 (2003). https://doi.org/10.1007/s00277-002-0588-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-002-0588-7

Keywords

Navigation